MedInvest

MedInvest MedInvest is a leading media, news, and conferencing company in the healthcare, biotech and medtech sectors.

MedInvest will host its Neurological Diseases and Mental Health Disorders Conference on September 8-10, 2021.  To regist...
08/08/2021

MedInvest will host its Neurological Diseases and Mental Health Disorders Conference on September 8-10, 2021. To register, visit medinvestconferences.com.

MedInvest will host its Neurological Diseases and Mental Health Disorders Conference on September 8-10, 2021. To register, visit medinvestconferences.com.

03/10/2021
Register to attend or present at the Spring Meeting on the Oncology Investor Conference Series sponsored by the National...
03/06/2021
Register | CancerCon

Register to attend or present at the Spring Meeting on the Oncology Investor Conference Series sponsored by the National Foundation for Cancer Research.

https://www.oncologyinvestorconference.com/register

All Investors are Screened and Must be Preapproved and Accredited.  Includes family offices, foundations, government grant making entities, venture and public funds, and angel groups.

A team of scientists at the Case Western Reserve University School of Medicine combines #nanotechnology with #immunother...
10/06/2020
Fighting breast cancer with nanotech, immunotherapy

A team of scientists at the Case Western Reserve University School of Medicine combines #nanotechnology with #immunotherapy to fight against metastatic breast cancer.

A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.

The Nobel Prize in Physiology or Medicine 2020 was awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. R...
10/05/2020
The Nobel Prize in Physiology or Medicine 2020

The Nobel Prize in Physiology or Medicine 2020 was awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice "for the discovery of Hepatitis C virus."

The Nobel Prize in Physiology or Medicine 2020 was awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice "for the discovery of Hepatitis C virus".

54 years ago, DeBakey performed the 1st successful placement of a left ventricular assist device on a patient with a his...
10/03/2020

54 years ago, DeBakey performed the 1st successful placement of a left ventricular assist device on a patient with a history of severe aortic insufficiency and mitral stenosis. The patient was ultimately discharged from the hospital and resumed normal activities.

54 years ago, DeBakey performed the 1st successful placement of a left ventricular assist device on a patient with a history of severe aortic insufficiency and mitral stenosis. The patient was ultimately discharged from the hospital and resumed normal activities.

Using machine learning to estimate risk of cardiovascular death
10/01/2020
Using machine learning to estimate risk of cardiovascular death

Using machine learning to estimate risk of cardiovascular death

A team from MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) came up with a machine learning model that can estimate, from the electrical activity of their heart, a patient’s risk of cardiovascular death.

Dr. Robert Gallo, Co-Discoverer of HIV/AIDs, discussing re-purposing the pollo vaccine in the war against COVID-19 at th...
09/29/2020

Dr. Robert Gallo, Co-Discoverer of HIV/AIDs, discussing re-purposing the pollo vaccine in the war against COVID-19 at the MedInvest Infectious Diseases Conference

https://www.medinvestconferences.com/post/dr-robert-gallo-speaks-about-re-purposing-polio-vaccine-in-the-war-against-covid-19

Dr. Robert Gallo, Co-Discoverer of HIV/AIDs, discussing re-purposing the pollo vaccine in the war against COVID-19 at the MedInvest Infectious Diseases Conference

https://www.medinvestconferences.com/post/dr-robert-gallo-speaks-about-re-purposing-polio-vaccine-in-the-war-against-covid-19

MedInvest will host its final investor conference of the year, the MedInvest Virtual Cardiovascular and Neurovascular Co...
09/29/2020
St. Jude Founder to Headline MedInvest Cardiovascular Investor Conference Scheduled for Dec 8-11

MedInvest will host its final investor conference of the year, the MedInvest Virtual Cardiovascular and Neurovascular Conference, on Tuesday, December 8 - Thursday, December 11. Companies and accredited investors can visit the "Register" tab on our website to apply to present, or attend, respectively.

https://www.medinvestconferences.com/post/st-jude-founder-to-headline-medinvest-cardiovascular-investor-conference-scheduled-for-nov-17-20

MedInvest, a leading healthcare, biotech, and medtech media and conference company, announced that it will host a virtual investor conference focused on cardiology, cardiovascular, and neurovascular on Tuesday, December 8 through Friday, December 11. The conference will be titled the MedInvest Cardi...

Medtronic Received FDA Breakthrough Device Designation for TYRX Driveline Wrap Devicehttps://www.medinvestconferences.co...
09/29/2020
Medtronic Received FDA Breakthrough Device Designation for TYRX Driveline Wrap Device

Medtronic Received FDA Breakthrough Device Designation for TYRX Driveline Wrap Device

https://www.medinvestconferences.com/post/medtronic-received-fda-breakthrough-device-designation-for-tyrx-driveline-wrap-device

Medtronic plc (NYSE:MDT) announced on Tuesday, September 22 that it had received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for its TYRX™ Absorbable Antibacterial Driveline Wrap (AADW). The TYRX™ AADW was designed to securely hold a percutaneous drive...

Address

230 Park Avenue, Suite 900
New York, NY
10169

Alerts

Be the first to know and let us send you an email when MedInvest posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Nearby media companies


Other Media/News Companies in New York

Show All